Published: 2018-07-26

Clinicopathological analysis of ovarian tumours: a 10 year retrospective study

Sahana N. Naik, Sunil Kumar K. S., Girija B.


Background: Ovarian tumors account for 30% of all cancers of female genital tract which represents the sixth most common cancer and fourth leading cause of death in women. The present study was done with an objective to determine the frequency and distribution of various ovarian tumors and to study their clinical and histopathological presentations.

Methods: It is a retrospective observational study of patients with ovarian tumors subjected to surgery in the department of obstetrics and gynecology, SDM College of Medical Sciences and Hospital from January 2005 to December 2015.

Results: There were 642 cases comprising of 77.7% of neoplastic lesions and 22.3% of non-neoplastic lesions. Majority of the ovarian tumors (83%) were seen in the age group of 20 to 50 years. Mean age for ovarian tumors was 38 years.  Among the neoplastic lesions 84% were benign, 14.2% were malignant and 1.8% were borderline tumors. Surface epithelial tumors were the commonest tumors (60.9%) followed by germ cell tumors (12.8%).  Serous cystadenoma was the most common benign tumors (47.1%) followed by mucinous cystadenoma (18.4%). Among the ovarian malignant tumors; serous cystadenocarcinoma was the most common (4.5%) followed by mucinous cystadenocarcinoma (2.6%). Chocolate cysts were the most common among the non-neoplastic lesions (36.4%).

Conclusions: Ovarian neoplastic lesions were more common than non-neoplastic lesions. Benign ovarian tumors were common in reproductive age group.  The mean age of occurrence for ovarian tumor was 38 years. The most common neoplasm was surface epithelial tumors, of which serous tumors was the commonest. Chocolate cysts were the most frequently encountered histopathological finding among the non-neoplastic lesions.


Histopathological types, Non neoplastic lesions, Ovarian tumors

Full Text:



Uma Devi K. Current status of gynecological cancer care in India. J Gynecol Oncol. 2009;20(2):77-80

Consolidated Report of Population Based Cancer Registries 2001-2004. National Cancer Registry Program Indian Council of Medical Research. Bangalore, 2006.

WHO classification of ovarian neoplasms. website. Available at: Accessed May 21st, 2018

Day NE, Krishnan E. Epidemiology of gynaecological cancers. Gynaecology by Shaw R W. 2nd ed. Edinburgh: Churchill Living Stone, 1997; 477-87.

Gentry-Maharaj A, Menon U. Screening for ovarian cancer in the general population. Best Practice Res Clin Obstetr Gynaecol. 2012;26(2):243-56.

Saxena HM, Devi G, Prakash P, Pankajam P. Ovarian neoplasms: a retrospective study of 356 cases. J Obstet Gynecol India. 1980;20(6):523-7.

Sharadha SO, Sridevi T, Renukadevi, Gowri R, Binayak D, Indra V. Ovarian Masses: Changing Clinico Histopathological Trends. J Obstetr Gynecol India. 2015;65(1):34-38

Yogambal M, Arunalatha P, Chandramouleeswari K, Palaniappan V. Ovarian tumours-Incidence and distribution in a tertiary referral center in south India. IOSR. J Dental Med Sci. 2014;13(2):74-80.

Mondal SK, Banyopadhyay R, Nag DR, Roychowdhury S, Mondal PK, Sinha SK. Histologic pattern, bilaterality and clinical evaluation of 957 ovarian neoplasms: a 10-year study in a tertiary hospital of eastern India. J Can Res Ther. 2011;7:433-7

Swamy GG, Satyanarayana N. Clinicopathological analysis of ovarian tumours: a study on five years samples. Nepal Med Coll J. 2010;12(4):221-3.

Mootha S, Dasari U. Clinico-pathological analysis of 100 ovarian tumours at a high-volume referral hospital. Int J Sci Res (IJSR).2015;4(1):238-41.

Soumini G, Sarella LK, Lakshmi Chaveli V, Gurugubelli S. Scenario of ovarian mass lesions at a teaching hospital in andhra pradesh India. Int J Reprod Contracept Obstet Gynecol. 2015;4:9829

Sheikh S, Bashir H, Farooq S, Beigh A, Manzoor F, Reshi R. Histopathological spectrum of ovarian tumours from a referral hospital in Kashmir valley, Jammu and Kashmir, India. Int J Res Med Sci. 2017;5(5):2110-4.

Wills V, Mathew R. A study on clinico-histopathological patterns of ovarian tumors. Int J Repr Contracept Obstetr Gynecol. 2017;5(8):2666-71.

Wasim T, Majrroh A, Siddiq S. Comparison of clinical presentation of benign and malignant ovarian tumours. J Pak Med Assoc Jan. 2009;59(1):18-21.

Murthy NS, Shalini S, Suman G, Pruthvish S, Mathew A. Changing trends in incidence of ovarian cancer- the Indian scenario. Asian Pac J Cancer Prev. 2009;10(6):1025-30.

Bhagyalakshmi A, Sreelekha A, Sridevi S, Chandralekha J, Parvathi G, Venkatalakshmi A. Prospective study of histopathological patterns of ovarian tumours in a tertiary care centre. Int J Res Med Sci. 2017;2(2):448-56.

Seiden MV. "Gynaecologic Malignancies". In Longo DL, Kasper DL, Jameson JL, Fauci AS, Hauser SL,Loscalzo J. Harrison's Principles of Internal Medicine (18th ed.). McGraw-Hill. 2012;810-813.

American College of Obstetricians and Gynecologists. Salpingectomy for ovarian cancer prevention. Committee opinion no. 620. Obstet Gynecol. 2015;125:279-81.

Blaustein A. Pathology of the female genital tract. 2nd edition Springer 1982:449-463.

Ashraf A, Shaikh AS, Ishfaq AY, Akram AB, Kamal FU, Ahmad NA. The relative frequency and histopathological pattern of ovarian masses. Biomedica. 2012;28(1):98-102.

Iyoke CA, Ifeadike CO, Nnebue CC, Nkwo PO, Ezugwu EC, Edosuyi L, et al. A Ten-Year Review of Ovarian Cancer in Enugu, South East Nigeria. Afr Med J. 2011;2(1):8-12.